These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 25870007)

  • 1. Vasopressin and disruption of calcium signalling in polycystic kidney disease.
    Chebib FT; Sussman CR; Wang X; Harris PC; Torres VE
    Nat Rev Nephrol; 2015 Aug; 11(8):451-64. PubMed ID: 25870007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.
    Brill AL; Ehrlich BE
    Cell Signal; 2020 Feb; 66():109490. PubMed ID: 31805375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling.
    Xu C; Rossetti S; Jiang L; Harris PC; Brown-Glaberman U; Wandinger-Ness A; Bacallao R; Alper SL
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F930-45. PubMed ID: 17090781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystin-2 Mediated Calcium Signalling in the
    Allan CY; Sanislav O; Fisher PR
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca
    Yanda MK; Liu Q; Cebotaru V; Guggino WB; Cebotaru L
    J Biol Chem; 2017 Oct; 292(43):17897-17908. PubMed ID: 28887310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tale of two tails: ciliary mechanotransduction in ADPKD.
    Cantiello HF
    Trends Mol Med; 2003 Jun; 9(6):234-6. PubMed ID: 12829010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review.
    Pietrzak-Nowacka M; Safranow K; Płońska-Gościniak E; Nowacki A; Późniak P; Gutowski P; Ciechanowski K
    Kidney Blood Press Res; 2024; 49(1):9-19. PubMed ID: 38096797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Autonomous Hedgehog Signaling Is Not Required for Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ma M; Legué E; Tian X; Somlo S; Liem KF
    J Am Soc Nephrol; 2019 Nov; 30(11):2103-2111. PubMed ID: 31451534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Mechanisms of ADPKD.
    Kim DY; Park JH
    Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of polycystins: insights into polycystic kidney disease.
    Douguet D; Patel A; Honoré E
    Nat Rev Nephrol; 2019 Jul; 15(7):412-422. PubMed ID: 30948841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
    Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
    J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of calcium in polycystic kidney disease: From signaling to pathology.
    Mangolini A; de Stephanis L; Aguiari G
    World J Nephrol; 2016 Jan; 5(1):76-83. PubMed ID: 26788466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.
    Magistroni R; Mangolini A; Guzzo S; Testa F; Rapanà MR; Mignani R; Russo G; di Virgilio F; Aguiari G
    BMC Nephrol; 2019 Sep; 20(1):355. PubMed ID: 31514750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease.
    Terryn S; Ho A; Beauwens R; Devuyst O
    Biochim Biophys Acta; 2011 Oct; 1812(10):1314-21. PubMed ID: 21255645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent function of polycystin 1 and polycystin 2 in cell size regulation.
    Viau A; Kotsis F; Boehlke C; Braeg S; Klein M; Nitschke R; Walz G; Kuehn EW
    Biochem Biophys Res Commun; 2020 Jan; 521(2):290-295. PubMed ID: 31668373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the cytoplasmic interaction between polycystin-1 and polycystin-2.
    Casuscelli J; Schmidt S; DeGray B; Petri ET; Celić A; Folta-Stogniew E; Ehrlich BE; Boggon TJ
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1310-5. PubMed ID: 19726544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.
    Bastos AP; Onuchic LF
    Braz J Med Biol Res; 2011 Jul; 44(7):606-17. PubMed ID: 21625823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
    Krappitz M; Bhardwaj R; Dong K; Staudner T; Yilmaz DE; Pioppini C; Westergerling P; Ruemmele D; Hollmann T; Nguyen TA; Cai Y; Gallagher AR; Somlo S; Fedeles S
    J Am Soc Nephrol; 2023 Jan; 34(1):110-121. PubMed ID: 36270750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
    de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
    Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.